Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Paradoxical embolization describes the passage of material, typically thrombus, from venous circulation into the systemic arterial circulation via a shunt. Presence of a right-to-left shunt is often the result of an atrial cardiac defect. In 1877, Dr. Julius Cohnheim, a Prussian pathologist, first proposed this mechanism after identifying a large atrial defect during the autopsy of a 35-year-old woman who suffered a fatal ischemic stroke. Three years later, Dr. Moritz Litten, a German internal medicine physician, further supported this proposition with an additional compelling case when an autopsy of a 43-year-old woman with multiple systemic emboli identified extensive femoral vein thrombosis. After enlisting the support of Professor Rudolf Virchow, closer inspection revealed a right atrial thrombus and a large atrial defect.
Paradoxical embolism was once thought to be an exceedingly rare cause of ischemic stroke, but multiple studies reported an increased prevalence of patent foramen ovale (PFO) in patients with cryptogenic stroke (stroke with unclear etiology), particularly in young patients, suggesting that paradoxical embolism may be more common than previously considered. Even still, given the heterogeneous nature of stroke and the high prevalence of PFO in the general population, it is challenging to determine the pathophysiologic relevance of PFO and right-to-left shunt in patients with stroke. While it has been of a topic of much debate, recent clinical trials have helped clarify the value of PFO closure for secondary stroke prevention in select patients. The following issues will be addressed in this chapter:
Pathophysiology of PFO in stroke
Complete evaluation of young patients with stroke
Medical management of PFO
Percutaneous closure of PFO
Atrial septal defects
Atrial septal aneurysms
Patients with PFO and underlying hypercoagulability
PFO is a common congenital cardiac finding. While in utero, the positioning of the septum primum and secundum acts as a one-way valve, facilitating right-to-left shunting of oxygenated blood provided via the umbilical vein. At the time of birth, pulmonary ventilation dramatically increases pulmonary perfusion and reverses the previous right-to-left pressure gradient, leading to a functional closure of the foramen ovale. In about 75% of healthy adults, permanent anatomical closure occurs via fibrous adhesions, while in the remaining 25%, the shunt persists, resulting in a PFO. The one-way nature of the valve is often preserved, so right-to-left shunting can occur when right-sided cardiac pressures increase, such as with Valsalva maneuver, coughing, or a number of pathologic conditions. Importantly, the right-to-left shunt acts as a potential conduit for paradoxical embolization, or it may also foster stagnant blood, ultimately promoting in situ thrombus formation. PFO may also be associated with increased risk of atrial arrhythmia.
The relationship between PFO and stroke is strongest among young patients with cryptogenic stroke in case-control studies. The Risk of Paradoxical Embolism (RoPE) study merged 12 cohorts of cryptogenic stroke patients, 2546 total patients, in order to investigate factors associated with the presence of PFO and to determine the likelihood that a patient's PFO was pathogenically related to the stroke ( Box 39.1 ). In brief, the younger the patient, and the fewer traditional risk factors present, the more likely a PFO is to be identified during the workup, and thus the more likely it was to have been involved in the genesis of the stroke. The score can help physicians counsel patients and determine a course of action. The higher the number, the more likely the PFO was to be related to the stroke, with a score of ≥6 suggesting that it is more likely than not that the PFO was pathogenic. While observational studies have been inconsistent, the presence of certain echocardiographic features may convey a higher risk of stroke ( Box 39.2 ). Finally, some clinical clues may suggest that a PFO was causally related to the stroke, including history of DVT or pulmonary embolism, recent prolonged travel, migraine, and a Valsalva-type maneuver at onset of the stroke.
Characteristics | Points (Add to Calculate Total Score) |
---|---|
No history of hypertension | 1 |
No history of diabetes | 1 |
No prior stroke or TIA | 1 |
Nonsmoker | 1 |
Presence of cortical infarct on imaging | 1 |
Age 18–29 years | 5 |
Age 30–39 years | 4 |
Age 40–49 years | 3 |
Age 50–59 years | 2 |
Age 60–69 years | 1 |
RoPE Score | PFO Attributable Fraction (95% CI) | 2-Year Stroke Risk (95% CI) |
---|---|---|
0–3 | 0% (0–4) | 16% (9–24) |
4 | 38% (25–48) | 9% (4–14) |
5 | 34% (21–45) | 3% (0–6) |
6 | 62% (54–68) | 4% (2–7) |
7 | 72% 9 66–76) | 2% (0–4) |
8 | 84% (79–87) | 3% (0–5) |
9–10 | 88% (83–91) | 1% (0–2) |
PFO , Patent foramen ovale; RoPE , risk of paradoxical embolism; TIA , transient ischemic attack.
Large size of PFO
Large right-to-left shunt
Spontaneous right-to-left shunt
Presence of atrial septal aneurysm
Greater PFO flap mobility
Prominent eustachian valve
Prominent Chiari network
PFO , Patent foramen ovale.
It is first important to discuss that there are multiple conditions that cause focal neurologic dysfunction that can mimic a stroke, but these would entail a different workup and treatment, as described in Table 39.1 . If a stroke is confirmed, secondary prevention depends on identifying the mechanism of the first event, if possible. Thus a thorough workup following a stroke is critical to optimally reducing stroke risk. Because of the high prevalence of PFO in the general population, and low risk of stroke related to PFO, it should not be considered the proximate cause until the workup is complete and an alternative source of stroke has been ruled out.
Stroke Mimic | Clinical Clues | Evidence |
---|---|---|
Atypical migraine |
|
|
Seizure |
|
|
Structural lesion (e.g., tumor, abscess, subdural hematoma) |
|
|
Metabolic derangement (e.g., hypoglycemia) |
|
|
Somatoform disorder (e.g., conversion) |
|
|
Table 39.2 reviews the various potential stroke etiologies that should be considered in a young patient. While stroke is a clinical diagnosis, evaluation typically starts with brain imaging. Computed tomography (CT) is useful in the emergency setting in order to exclude an intracerebral hemorrhage, but in the absence of clear ischemic injury on CT, magnetic resonance imaging (MRI) may provide more information regarding the size and distribution of infarcts, timing, and evidence of chronic strokes. While MRI is not always necessary, in the context of young patients with unclear cause of stroke, MRI is helpful to identify acute and/or chronic infarcts in multiple territories, which would be consistent with cardioembolism. Alternatively, MRI may confirm that the injury is exclusively small-vessel disease.
Stroke Etiology | Frequency | Clinical Clues | Evidence |
---|---|---|---|
Cardioembolism |
|
|
|
Arterial dissection |
|
|
|
Vasoactive drugs |
|
|
|
Hematologic abnormality |
|
|
|
Large artery atherosclerosis |
|
|
|
Small artery disease |
|
|
|
Vasculitis |
|
|
|
Mitochondrial disease |
|
|
|
CADASIL |
|
|
|
Vascular imaging is critical to addressing the possibility of a large artery process. If the stroke occurred within the distribution of the carotid arteries, Doppler ultrasonography is a reasonable minimal screening test for carotid bifurcation disease. However, it is important to note that dissection is a common mechanism for stroke in young patients, and ultrasound is not as sensitive to detect dissection, as the lesion is often more distal than ultrasound can insonate. Thus CT angiogram or MR angiogram (MRA) of the head and neck is appropriate to more thoroughly evaluate the complete cervicocephalic vasculature, in addition to the posterior circulation (vertebrobasilar system). This may also provide insight into the possibility of an underlying vasculopathy. If a vasculopathy is identified and is of uncertain cause, a conventional angiogram may also be warranted.
A complete cardiac workup is critical to ruling out a cardiac source of embolism. Although it is considerably less prevalent in younger populations, atrial fibrillation is a well-characterized cause of stroke. All patients should have an EKG and at least 24 hours of rhythm monitoring during admission. After discharge, long-term monitoring increases the likelihood of capturing occult atrial fibrillation, but the low rate of atrial fibrillation in patients under 45 likely limits the utility in that population. Every stroke patient should undergo an echocardiogram to assess for cardioembolic sources such as reduced ejection fraction, cardiomyopathy, regional wall motion abnormalities, noncompaction, valvular vegetations, tumors, intracardiac thrombus, aortic arch atheroma, and of course PFO. The gold standard for PFO detection is direct visualization of intracardiac shunting with agitated saline during transesophageal echocardiogram (TEE). TEE is also most sensitive to detect valve lesions, left atrial appendage thrombus, and aortic pathology. Transthoracic echocardiography is most helpful to identify ventricular pathology and is generally less sensitive for detection of PFO. For detection of right-to-left shunt, transcranial Doppler ultrasonography (TCD) of the cerebral vessels during intravenous injection of agitated saline is comparable to TEE, but fails to directly visualize the PFO, cannot differentiate cardiac from noncardiac right-to-left shunts, and most importantly, does not allow for detection of other mechanisms of stroke and transient ischemic attack (TIA) originating in the heart and aorta.
Laboratory studies address a number of common and uncommon causes of stroke. As a part of the initial evaluation, a complete blood count, prothrombin time, partial thromboplastin time, cholesterol panel, and hemoglobin A1C should be collected. Inflammatory markers such as ESR or CRP are an appropriate screen for vasculitis—in particular temporal arteritis in the older population. If there is concern for vasculopathy or vasculitis, a more comprehensive autoimmune screen is warranted, but will not be described in detail here. In patients thought to be at risk of cancer with an otherwise unexplained stroke mechanism, an elevated D-dimer may increase concern for hypercoagulability of malignancy, and elevated pro-BNP may increase the suspicion of occult atrial fibrillation. A toxicology screen should be performed in all patients because of the relationship between sympathomimetic drugs and stroke with or without vasculopathy. The potential relationship between stroke and marijuana remains controversial, but there are recent reports of stroke associated with use of synthetic cannabinoids. In young patients with first stroke, strong family history of early stroke or known thrombophilia, or recurrent unexplained stroke, a hypercoagulable screen beyond basic coagulation studies should be performed. In the acute setting, this should include prothrombin gene mutation, factor V Leiden, homocysteine, and antiphospholipid antibody panel (including lupus anticoagulant, anticardiolipin antibodies, and beta-2-glycoprotein). After the acute phase, protein C, protein S, and antithrombin III can be measured, as these values may be perturbed in the setting of acute thrombosis. For a more detailed description of the thrombophilia workup, please refer to Chapter 22 , Box 22.1 .
If a complete stroke workup ( Box 39.3 ) reveals a potential cause of stroke, such as large vessel atherosclerosis, arterial dissection, or atrial fibrillation, secondary stroke prevention should target this known mechanism. Because PFO is common, associated with a low risk of stroke relative to other known mechanisms, and can reasonably be treated with antiplatelet or anticoagulant medication described as follows, it should generally be considered incidental if another compelling mechanism is identified.
Brain imaging:
MRI to fully characterize the distribution of acute lesions as well as chronic lesions
Vessel imaging of head and neck:
CTA or MRA to identify large vessel atherosclerotic process, underlying vasculopathy, or dissection
Conventional angiogram may be necessary to fully exclude underlying vasculopathy if high index of suspicion or concern based on noninvasive imaging
Cardiac workup:
Transthoracic and/or transesophageal echocardiogram to identify potential cardiac source of emboli, such as reduced ejection fraction, segmental wall motion abnormalities, valvular vegetation, aortic athero, thrombus, or mass. Agitated saline “bubble” study to assess for right-to-left shunting
EKG and telemetry while in hospital, in addition to long-term rhythm monitoring for atrial fibrillation after discharge (lower utility in young patients)
Lab work:
Lipid panel and Hgb A1C to screen for modifiable stroke risk factors
Toxicology screen
ESR and RPR to screen for treatable infection, inflammation, or malignancy
Hypercoagulable screen (while not a component of every stroke, it is appropriate in a young patient with PFO and no alternative etiology, or when there is family history of hypercoagulability)
MRI , Magnetic resonance imaging; MRA , magnetic resonance angiogram; PFO , patent foramen ovale.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here